on brain MRI of asymptomatic aging adults is WMH, or "leukoaraiosis." Defined by Hachinski in 1985, "leukoaraiosis" implies "diminished density of white matter which is seen on brain-computed tomography (CT)," which in turn is hyperintense on T2-weighted, proton-density-weighted, and fluid-attenuated inversion recovery (FLAIR) brain MRI sequences [2, 3] . Over the years, MRI has demonstrated greater sensitivity in detecting abnormal white matter, including lesions not otherwise visible on head CT [4] .
Radiographic assessment of WMH severity
There are primarily two radiographic approaches to the assessment of WMH severity (Fig. 1) . First, the visual rating scales that are used to measure white matter lesions (WMLs) on CT or MRI are based on the location and severity of white matter disease. MRI-based scales, such as the Fazekas scale, rate both periventricular hyperintensity (PVH) and deep white matter locations of WML (score 0-3) [5] . The Scheltens scale adds the location, size, and number of WML in PVH (score 0-6), WMH (score 0-24), basal ganglia hyperintensities (BG) (score 0-30), and infratentorial foci of hyperintensities (ITF) (score 0-24) [6] . The Rotterdam Scan Study (RSS) scale rates WML in the periventricular region (score 0-9) and subcortical WML [7] . The Age-Related White Matter Changes (ARWMC) scale for rating WMH on CT and MRI include the location, size, and number of WMLs (score 0-3) and basal ganglia lesions (score 0-3) in five different regions (frontal, parieto-occipital, temporal, basal ganglia, and infratentorial) of the bilateral hemispheres [8] .
Second, a volumetric approach to WMH analysis has been based on the various semi-automated protocols, using analytical software such as Sparc 5 (SUN, Palo Alto, CA) [9] or MRIcro (University of Nottingham School of Psychology, Nottingham, UK; www.mricro.com), which quantify WMH Figure 1 . Severity of MRI-detected white matter hyperintensity. Total burden of white matter disease varies significantly among asymptomatic adults and patients with known cerebrovascular disease. In age-matched individuals, white matter hyperintensity (WMH) volume may vary from mild to very severe (upper panel). Using validated semi-automated volumetric protocol, WMH volume can be quantified (lower panel, in red, WMH maps are derived from contiguous supratentorial axial T2-FLAIR MRI slices using previously published method [10] ) with a high degree of accuracy and precision.
volume (WMHv) on axial FLAIR of either the entire brain or just the supratentorial region [10] (Fig. 1) . Albeit more labor-intense, volumetric methods provide more accuracy and reliability in assessing WMH severity, especially when evaluating WMH progression, as compared to the visual rating scales [11, 12] . Some WMH progression scales, such as the Rotterdam Progression and Schmidt Progression scales, are also sensitive, consistent, and relate to volumetric volume change [12] .
Clinical application of different scales may depend on their sensitivity for a specific functional domain. For example, in the Leukoaraiosis And DISability (LADIS) study, visual rating scale and volumetric methods demonstrated greater WMH burden in subjects with impaired physical performance and cognition as compared to normal controls [13] . However, volumetric assessment was more sensitive than visual scores in detecting memory symptoms [9] . Many studies have used WMHv to evaluate the association between leukoaraiosis and risk of stroke, cognitive impairment, dementia, mortality, stroke severity, and other functional disabilities.
Burden of WMH and risk of stroke
Risk of first-ever stroke in population-based studies
Six large prospective population-based studies provided pivotal evidence of correlation between WMH and risk of first-ever stroke ( Table 1) . The Atherosclerosis Risk in Communities (ARIC) study followed up 1,684 persons in four U.S. communities for 4.7 years and found that people with WML had a higher 5-year cumulative incidence of clinical stroke than people without WML (6.8 % vs. 1.4 %; RR 3.4; 95 %.CI, 1.5-7.7), independent of common stroke risk factors [14] . The Rotterdam Scan Study in the Netherlands, which followed 1,077 participants for an average of 4.2 years, demonstrated that WML in both periventricular and subcortical locations significantly increased the risk of stroke [15] . The Cardiovascular Health Study (CHS) included 3,293 persons in four U.S. communities followed for an average of 7 years, and showed that the risk of stroke increased proportionally to the WMH grade increase, independent of conventional stroke risk factors [16] . A prospective cohort study in Shimane, Japan, demonstrated that marked PVH and subcortical white matter lesion (SWML) burden independently increased the risk of stroke in 2,684 subjects followed for an average of 6.3 years [17] . The Three-City (3C) study in Dijon, France, which followed 1,643 persons for an average 4.9 years, showed a significant increase in the risk of stroke with increasing WML [18] . And finally, the Framingham Offspring Study, which systematically evaluated 2,177 persons during 5.6 years of follow-up, demonstrated that greater WMHv was associated with an increased risk of stroke (HR 2.28, 95 % CI, 1.02-5.13), independent of vascular risk factors [19] .
The meta-analysis of these six large population-based cohort studies demonstrated a significant association of WMH with risk of stroke (HR 3.1, 95 % CI, 2.3-4.1, pG0.001) [20•] . Furthermore, a pooled population-based analysis of the ARIC and CHS, which included 4,872 stroke-free individuals followed for a median of 13 years, demonstrated that higher WMH grade on baseline MRI is a significant predictor of spontaneous intracerebral hemorrhage (ICH) (p for trend G 0.0001) [21] .
Risk of stroke in high-risk populations
Many prospective studies have evaluated WMH and risk of stroke in high-risk populations (Table 1) . A study in 89 Japanese participants who had clinical lacunar infarction and who were followed up for a mean of 51 months found that extensive WMH at baseline was a significant predictor of stroke risk (RR 1.60; 95 % CI, 1.02-2.54, pG0.05) [22] . A study in 121 American patients with lobar ICH demonstrated that CT-based evidence of white matter damage nearly quadrupled the risk of recurrent ICH (HR 3.7, 95 % CI, 1.1-12.3, p=0.02) after 2.7 years of follow-up [10] . A study of 81 Swedish patients with lacunar infarction found that severity of WML was a predictor of recurrent stroke (OR 1.7, 95 % CI, 1.2-2.7), in long-term follow-up (5 years) [23] . Similarly, extensive WML was associated with recurrent stroke in a study of 228 Chinese patients with stroke (p=0.0001) [24] . The Amsterdam Vascular Medicine Group in the Netherlands reported that patients (n=230) with confirmed atherosclerotic disease -including recent myocardial infarction (MI), ischemic stroke (IS), or peripheral arterial disease (PAD) -and evidence of PVH on neuroimaging had a higher recurrent ischemic stroke rate at 3.5 years compared to those without PVH (18 % vs. 5 %, p=0.001) [25] . A study in 266 Japanese patients with ischemic stroke or ICH found that the subgroup of patients with advanced WMH but no microbleeds had the highest recurrence rate of ischemic stroke of the four patient subgroups (10.5 % in 1-year and 17.4 % in 2-year follow-up, HR 10.7, 95 % CI, 2.6-43.7) [26] . Finally, combined data analyses demonstrate convincingly that WMH severity is linked to the risk of recurrent stroke. A meta-analysis from three studies in high-risk populations reported HR 7.4, 95 % CI, 2.4- Burden of WMH and risk of vascular cognitive impairment and dementia
Risk of vascular cognitive impairment
There have been multiple population-based studies that have evaluated the association between leukoaraiosis and the risk of cognitive impairment (Table 2) . Some studies used the severity of WMH at baseline, while many assessed the progression of WMH longitudinally. A study in 67 American participants with normal cognition demonstrated that high baseline WMHv was related to the risk of progression to mild cognitive impairment (MCI) (HR 3.3; 95 % CI, 1.33-8.2, p=0.01) [27] . However, the Framingham Offspring Study, which followed up 1,694 persons for a mean duration of 6.2 years, found that the severity of WMHv did not correlate with the risk of all MCI or amnestic MCI [19] . Similarly, the Austrian Stroke Prevention Study followed 329 participants for 6 years and demonstrated that WMHv progression was associated with cognitive decline in some domains, including memory, conceptualization, and visuopractical skills, but that changes in WMHv were not related to cognitive decline after adjustment for brain volume [28] .
Risk of dementia
The link between severity of leukoaraiosis and risk of dementia has been examined in a number of large prospective population-based studies (Table 2) , including the Cardiovascular Health Cognitive Study, in which 480 of 3,608 persons developed dementia in up to 8 years of follow-up. The study found that extensive WMH grade at study baseline was a significant risk factor for dementia (HR 1.8) and Alzheimer's disease (AD) [29] . The Rotterdam Scan Study demonstrated that WML, predominantly in the periventricular region, independently increased the risk of dementia in 1,077 cognitively intact participants at 5.2 years (HR 1.67; 95 % CI, 1.25-2.24) [30] . Similarly, the Osaki-Tajiri Project in Japan followed 204 healthy adults and 335 participants with questionable dementia for a period of 5 years and showed that WML was a predictor for progression to vascular dementia (VaD) [31] . The Framingham Offspring Study (n=2,013) reported that severity of WMHv was significantly associated with increased risk of dementia (HR 2.22, 95 % CI, 1.32-3.72 for WMHv; HR 3.97, 95 % CI, 1.10-14.3 for extensive WMHv) in a mean follow-up of 5.9 years [19] . Lastly, a meta-analysis of three population-based studies confirmed a significant association between WMH and risk of all types of dementia (HR 2.9; 95 % CI, 1.3-6.3, p=0.008) [20•] .
WMH as biomarker of total burden of cerebrovascular disease Association with mortality
Several large prospective population-based studies have evaluated the association between WMH and mortality (Table 1 ). In a cohort of 2,684 neuro- Abbreviations: AD -Alzheimer disease, ARWMC -age-related white matter changes, CI -confidence interval, HR -hazard ratio, LADISLeukoaraiosis and Disability study, MCI -mild cognitive impairment, OR -odds ratio, PVH -periventricular hyperintensity, SD -standard deviation, WML -white matter lesions, WMH -white matter hyperintensity, WMHv -WMH volume, VaD -vascular dementia logically normal and stroke-free Japanese subjects, the risk of death at 6. Other studies evaluated the association of leukoaraiosis with mortality in high-risk populations. A study in southern Norway in 134 persons with firstever ICH showed that severe WMH was independently associated with both short-and long-term fatality in 30-day survivors [34] . Similarly, survival was reduced in 228 Chinese subjects with WML with first-ever ischemic stroke when followed for a median of 23 months (p=0.007) [24] .
Association with stroke severity and post-stroke outcomes Severity of leukoaraiosis has been linked to poor functional post-stroke outcome in both short-(90 days) and long-term follow-up studies (Table 1 ). In patients with acute ischemic stroke, severity of WMH is significantly associated with poor functional outcome at 3 months [35] [36] [37] [38] [39] and beyond [39, 40] . When the topography of WML is considered, PVH burden -but not subcortical or deep WMH -appears to be linked to unfavorable clinical outcome in both short-and long-term (9 90 days) studies [35, 36, 39] . A study in patients with spontaneous ICH also showed that higher leukoaraiosis burden was an independent marker of worse functional outcome [38] .
In addition to being a predictor of functional outcome after stroke, severity of leukoaraiosis was independently associated with larger infarct cores [41] , greater infarct volume growth [42] , and increased risk of hemorrhagic transformation and parenchymal hematoma following intra-arterial thrombectomy for treatment of acute ischemic stroke, especially leukoaraiosis in the deep white matter region [43] .
Association with other functional disabilities
The Leukoaraiosis And DISability (LADIS) study is a European multicenter collaboration evaluating the independent role of white matter change by neuroimaging in determining many clinical aspects of disability, such as functional status, cognition, mood, motor performance, and urinary problems [44] ( Table 2 ). In the LADIS study's assessment of 639 nondisabled participants, moderate and severe white matter changes were independently associated with worsening of gait and balance, [45] whereas progression of leukoaraiosis was associated with a gradual decline in executive function test performance [46] . One-year reassessment of 619 elderly LADIS subjects with baseline functional independence demonstrated that severe WMH placed them at risk of dependency from motor and cognitive decline in a short time period [47] . Finally, the LADIS participants with severe baseline WMH and WMH progression over the course of a 3-year follow-up had a greater risk of gait and stance abnormalities, upper motor signs, and finger-tap slowing (fine motor movement), independent of other vascular lesions [48] .
Similarly, the Oregon Brain Aging Study (OBAS), which followed 104 cognitively intact participants for up to 13 years, demonstrated that increased total and periventricular WMHv at baseline and progression of PVH correlated with gradual gait worsening, whereas progression of subcortical WMH was associated with memory decline [49] . Finally, a number of studies reported the association between urinary incontinence and white matter changes [50] [51] [52] . Furthermore, urinary urgency was linked to the initial severity of WMH among the LADIS participants, independent of other confounders and vascular brain lesions [53] .
Future directions
The role of WMH as a diagnostic and prognostic biomarker of cerebrovascular disease is now commonly accepted. The question remains whether WMH plays an active role in the pathophysiology of cerebral dysfunction linked to the severity and progression of leukoaraiosis. Novel methods of clinical research, including genome-wide association studies (GWAS) and advanced neuroimaging techniques, may provide evidence of underlying disease biology in WMH. Of particular interest is the recent report on a shared genetic contribution between WMH severity assessed on brain MRIs of healthy aging adults enrolled through the multiple population-based cohorts of the CHARGE consortium [54•] and hospital-based cohorts of patients with acute ischemic stroke [55] . In a meta-analysis of WMH GWAS in 9,361 stroke-free individuals of European descent, the CHARGE consortium identified six novel single-nucleotide polymorphisms (SNPs) from a locus on chromosome 17q25 associated with WMH burden [54•] . The association of these SNPs -and most significantly, rs9894383 (p=0.0006) -with WMHv in ischemic stroke patients was replicated by the International Stroke Genetics Consortium study [55] , which represents a major breakthrough in understanding the shared genetic contribution to leukoaraiosis across the spectrum of small cerebral vessel disease.
Future breakthroughs are also expected to emerge from advanced neuroimaging of white matter in health and disease, among which diffusion tensor imaging (DTI) is most promising. DTI provides detailed data on the white matter structure (and in recent studies, the association between common vascular risk factors such as hypertension and serum lipids), and DTI measure of white matter integrity that has been explored in healthy adults [56, 57] . If validated, these preliminary reports of the effect of resting blood pressure and serum LDL on white matter integrity warrant further assessment in subjects with advanced WMH.
Conclusion
The body of literature supports the role of WMH as a biomarker of longstanding cerebrovascular disease. Advanced neuroimaging and future studies of genetic architecture of leukoaraiosis will reveal the underlying bi-
